Facio Fernando Nestor, Nagle Spessoto Ana Clara, Warick Facio Maria Fernanda, Fava Spessoto Luís Cesar
Urology, Faculty of Medicine of São José do Rio Preto (FAMERP), São José do Rio Preto, BRA.
Internal Medicine, Medical School of Catanduva, Catanduva, BRA.
Cureus. 2022 Jan 18;14(1):e21357. doi: 10.7759/cureus.21357. eCollection 2022 Jan.
Background The rapid dissemination of the coronavirus 2019 (COVID-19) had dramatic effects on individuals and healthcare systems in 2020. At our tertiary hospital, surgeries were recommended for patients at high oncological risk, with the prioritization of the maintenance of care and treatment of cancer. We aimed to assess the impact of the pandemic on the diagnosis and treatment of patients with urological tumors under the care of a university hospital. Materials and methods A retrospective analysis was performed of the charts of patients with urological tumors (prostate, kidney, bladder, and testicle) under the care and treated surgically at the Hospital de Base in 2019 and 2020, independently of ethnicity. The results were compared by the chi-square test (with a significance level of 5%). Results A discrete increase occurred in the quantity of appointments in 2020 (n = 5,846) compared to 2019 (n = 5,726). The most frequent types of cancer in 2019 and 2020 were, respectively, prostate (70.97% and 73.37%), bladder (18.07% and 12.52%), kidney (7.96% and 8%), and testicle (29.24% and 70.76%). Analyzing 279 surgeries performed on patients with prostate tumors, a 12.7% increase occurred in the year of the pandemic. Analyzing 271 surgical procedures on patients with bladder cancer, no considerable change occurred. Conclusion The analysis of the impact of the pandemic on the diagnosis and treatment of patients with urological tumors at a university hospital revealed a discrete increase in the number of outpatient appointments and a slight reduction in the number of patients and surgical procedures in the year of the pandemic (2020). More surgical procedures were conducted on patients with prostate cancer in 2020. More patients with bladder cancer sought medical care in the year of the pandemic, and practically the same quantity was submitted for surgical treatment. There was no statistically significant difference among types of cancer.
背景 2019 冠状病毒病（COVID-19）的迅速传播在 2020 年对个人和医疗系统产生了巨大影响。在我们的三级医院，建议对具有高肿瘤学风险的患者进行手术，优先维持癌症的护理和治疗。我们旨在评估大流行对大学医院护理下的泌尿肿瘤患者的诊断和治疗的影响。
材料与方法 对 2019 年和 2020 年在基础医院接受护理并接受手术治疗的泌尿肿瘤（前列腺、肾脏、膀胱和睾丸）患者的病历进行回顾性分析，不考虑种族。通过卡方检验比较结果（显著性水平为 5%）。
结果 与 2019 年（n = 5726）相比，2020 年的预约数量有离散增加（n = 5846）。2019 年和 2020 年最常见的癌症类型分别为前列腺癌（70.97%和 73.37%）、膀胱癌（18.07%和 12.52%）、肾癌（7.96%和 8%）和睾丸癌（29.24%和 70.76%）。分析对前列腺肿瘤患者进行的 279 例手术，大流行年份增加了 12.7%。分析对膀胱癌患者进行的 271 例手术，没有发生显著变化。
结论 对大流行对大学医院泌尿肿瘤患者的诊断和治疗的影响分析显示，门诊预约数量有离散增加，大流行年份（2020 年）患者数量和手术数量略有减少。2020 年对前列腺癌患者进行了更多的手术。在大流行年份，更多的膀胱癌患者寻求医疗护理，接受手术治疗的数量实际上相同。不同癌症类型之间没有统计学上的显著差异。
